Urology Department, University Hospital of Cruces Cruces Plaza, Bizkaia, Spain.
Surgery, Radiology and Physical Medicine Department, University of the Basque Country Barrio Sarriena s/n, Bizkaia, Spain.
Prog Transplant. 2024 Dec;34(4):199-203. doi: 10.1177/15269248241288568. Epub 2024 Oct 13.
Lymphocele is a common complication post-kidney transplantation, influenced by various factors including surgical technique, graft vessel count, operator experience, body mass index, ischemia time, and immunotherapy regimens.
The purpose of this study was to evaluate lymphocele risk factors, particularly focusing on the role of end-stage kidney disease.
A retrospective study was conducted on renal transplant recipients from a single center (March 2020 to December 2022). Patients were categorized into those developing lymphocele and those without during the postoperative period. Data, including sociodemographic, personal history, graft-related variables, intervention, and postoperative outcomes, were collected from electronic medical records.
Out of 291 renal transplant recipients, 57 (19.6%) developed postoperative lymphocele, with 15 (5.1%) being symptomatic. Patients with body mass index <24.9 kg/m2 have lower risk of developing lymphocele with an Odds Ratio of 0.538 (P=0.046). Higher lymphocele prevalence was noted in patients with chronic tubulointerstitial nephritis (46.2%; OR 3.815; P=0.024). Focal segmental glomerulosclerosis patients showed no lymphocele (0.0%; OR 0.123; P=0.048). Other factors, including autosomal dominant polycystic kidney disease, did not exhibit significant differences in lymphocele prevalence.
The etiology of end-stage kidney disease can serve as a significant predictor of lymphocele development during the postoperative period following renal transplantation. Further larger prospective studies are required to comprehensively assess risk factors and explore end-stage kidney disease potential role in predicting lymphocele formation.
肾移植后发生淋巴囊肿是一种常见并发症,其发生受到多种因素的影响,包括手术技术、移植血管数量、术者经验、体重指数、缺血时间和免疫治疗方案等。
本研究旨在评估淋巴囊肿的危险因素,特别是关注终末期肾病的作用。
对单中心(2020 年 3 月至 2022 年 12 月)的肾移植受者进行回顾性研究。将术后发生淋巴囊肿的患者和未发生的患者分为两组。从电子病历中收集数据,包括社会人口统计学、个人史、移植物相关变量、干预措施和术后结果。
在 291 例肾移植受者中,57 例(19.6%)发生术后淋巴囊肿,其中 15 例(5.1%)有症状。体重指数<24.9kg/m2的患者发生淋巴囊肿的风险较低,优势比为 0.538(P=0.046)。慢性肾小管间质性肾炎患者的淋巴囊肿患病率较高(46.2%;OR 3.815;P=0.024)。局灶节段性肾小球硬化症患者未发生淋巴囊肿(0.0%;OR 0.123;P=0.048)。其他因素,包括常染色体显性多囊肾病,在淋巴囊肿患病率方面没有显著差异。
终末期肾病的病因可作为肾移植后术后发生淋巴囊肿的重要预测因子。需要进一步开展更大规模的前瞻性研究,以全面评估危险因素,并探讨终末期肾病在预测淋巴囊肿形成中的潜在作用。